The Battle Between Innovation and Bullying Tactics: TAV 7

Aug.12.2022
The Battle Between Innovation and Bullying Tactics: TAV 7
The 7th episode of TAV 7 focuses on the battle between innovation and bullying tactics in reducing tobacco harm.

The seventh episode of "The Advocates' Voice" (TAV 7) is titled "The Battle between Innovation and Bullying Tactics," and is organized by the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA).


The group is composed of public relations experts and medical publishing observer Jena Fetalino, who emphasized that the abuse suffered by advocates of tobacco harm reduction (THR) and the industry reflects only one thing. According to Ms. Fetalino, "This shows that anti-smoking groups no longer have a reason to defend their case and resort to defamation to demonize the smoking industry, nicotine consumers, THR advocates, and the entire THR.


She urged THR advocates around the world not to remain silent but to confront "fake news" head-on. "Their response should be direct, straightforward, and simple so that people can understand the issue, no matter how complicated it may be. Even if attackers choose to focus on areas below the seat belt, we should remain calm, state the facts to provide information, not insults... We should have enough patience to clarify the issue by stating our position, denying inaccurate information, and correcting mistakes." We should have the facts and evidence at our fingertips. In the end, readers will discover what is true," she said.


A new form of attack.


The director of the Pakistan Association of Smoking Alternatives (ASAP) has stated that the reduction of tobacco harm is now facing new attacks. "Once opponents of THR can no longer attack the science, they will turn their focus towards advocates and consumers. These attacks must be based on facts, to expose any flaws in their narrative and to show that you are not an easy target.


The Director of the Thailand Tobacco Control Board (ECST), Asa Saligupta, has stated that the positive results achieved by reducing the harm caused by tobacco are worth the effort. Saligupta said: "If everyone thinks 'why bother doing this, it's too hard,' then nothing will happen... I myself have re-evaluated my own health after quitting smoking and going back to it. I look at my friends, especially my son, who quit smoking with the help of tobacco control efforts... without reducing tobacco harm, it would not be possible. They have prospered because of it.


Finally, Fasalinos emphasized the importance of patience and perseverance when concluding the discussion. He stated that it is necessary to maintain patience while adhering to our principles and moral standards and not yield to blackmail. This is the message he wished to convey.


Statement:


This article is compiled from third-party information and is only intended for industry exchange and learning purposes.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The translation of this article is only intended for industry-related discussion and research purposes.


Due to limitations in our ability to translate accurately, the translated version of the article may not fully reflect the original text. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on all domestic, Hong Kong, Macau, Taiwan, and foreign related statements and positions.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million
Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million
Ispire Technology reported financial results on May 7, 2026, for the third quarter of fiscal 2026, covering the three months ended March 31, 2026. Revenue was $18.7 million, compared with $26.2 million in the third quarter of fiscal 2025 and $20.3 million in the prior quarter. Gross profit was $2.0 million, with gross margin of 10.7%. Net loss was $9.5 million, or $0.17 per share. The company said it held $18.0 million in cash as of March 31, 2026, up $468,000 sequentially.
May.08 by 2FIRSTS.ai
From Brands to Supply Chains: 2Firsts Builds a PMTA Compliance Service System for the U.S. Market
From Brands to Supply Chains: 2Firsts Builds a PMTA Compliance Service System for the U.S. Market
2Firsts supports new tobacco and nicotine companies entering the U.S. market with full-chain PMTA compliance services.
Jun.04
India Seizes $14 Million Worth of Illegal Vaping Products Imported From China
India Seizes $14 Million Worth of Illegal Vaping Products Imported From China
India’s Directorate of Revenue Intelligence (DRI) seized approximately 300,000 illegal e-cigarettes and vaping devices worth more than ₹120 crore (approximately $14 million) during coordinated multi-state enforcement operations.
Regulations
May.22
KT&G Overseas Tobacco Revenue Jumps 24.6%, Attracting Global Capital
KT&G Overseas Tobacco Revenue Jumps 24.6%, Attracting Global Capital
South Korean tobacco company KT&G is drawing growing global investor attention after reporting record overseas tobacco sales, with international institutions including Capital Group and BlackRock increasing their stakes.
Business
May.19
How AI Is Rewriting the Talent Playbook for the Nicotine Industry: JTI’s Case
How AI Is Rewriting the Talent Playbook for the Nicotine Industry: JTI’s Case
AI is moving from a back-office tool to a core organizational capability in the nicotine industry. Based on JTI’s responses, this 2Firsts feature examines how AI is reshaping talent strategy, internal mobility, decision-making and human accountability as global tobacco companies compete in the shift toward new nicotine categories.
Jun.17
UK Tobacco and Vapes Bill Receives Royal Assent, Banning Tobacco Sales to People Born After 2008
UK Tobacco and Vapes Bill Receives Royal Assent, Banning Tobacco Sales to People Born After 2008
The UK government announced on April 29 that the Tobacco and Vapes Bill had received Royal Assent and become law. Under the new law, it is illegal to sell tobacco to anyone born on or after Jan. 1, 2009. The government said the law creates the UK’s first “smoke-free generation” and includes measures to ban the advertising and sponsorship of vapes and nicotine products, as well as powers to restrict packaging, branding and displays designed to appeal to children.
Apr.30 by 2FIRSTS.ai